Home
Categories
Ingredients
Packaging
Regulatory
Manufacturing
Company news
Body Care
Colour Cosmetics
Fragrance
Hair Care
Skin Care
Male Grooming
Digital
Marketing
Retail
Distribution
Recruitment
Pure Beauty
Job board
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Demetrix
Demetrix
Activities:
Ingredients
Trending Articles
Cosmetics Business reveals the top 5 skin care trends of 2026 in new report
K-beauty spicules, barrier hero ingredient beta-glucan and support for cosmetic treatments are among the skin care trends on the rise this year
LVMH introduces Deputy CEO of Parfums Christian Dior and LVMH Beauty Division
Philippe Farnier steps into this newly created role, reporting to Véronique Courtois, Chairman and CEO of Parfums Christian Dior and the LVMH Beauty Division
Henkel acquires Not Your Mother’s, strengthening US hair care portfolio
The German consumer goods giant has acquired the hair care and styling brand, with the deal also including the parent company of Not Your Mother’s, DeMert Brands.
Beauty Bay saved from administration
The online beauty retailer has been sold to an international investment group after filing for administration in February
You need to be a subscriber to read this article.
Click here
to find out more.
Cosmetics Business picks: 9 new beauty launches for March 2026
Skin care by Tatcha and Dr Barbara Sturm, fine fragrances from Chanel and Dolce & Gabbana and new era technology from Shark Beauty and FaceGym make up some of the biggest...
Upcoming event
PCPC Beauty Collective Summit 2026
23-25 March | Miami, US
See all
Related Content
Ingredients
Cosmetics Business in conversation with Demetrix
The leading Berkeley, California-based, biotechnology company discusses the future of cannabinoids in personal care
Ingredients
Demetrix and Evonik sign supply agreement for cannabinoids
Partnership introduces bioactives to global beauty and personal care markets
Manufacturing
Demetrix initiates 2022 commercial manufacturing campaign
Demetrix has progressed its cannabinoid production from proof of concept to commercial scale to support sales in a little over three years
Subscribe now